D. Tamura

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
D. Tamura, Daisuke Tamura
Publication record
33 papers · 1,565 citations · H-index 18

PAPERS

Impact of Tight Junction Protein ZO-1 and TWIST Expression on Postoperative Survival of Patients with Hepatocellular Carcinoma
201622 citationsauthor #15
Contents Vol. 34, 2016
20160 citationsauthor #80
Slug increases sensitivity to tubulin-binding agents via the downregulation of βIII and βIVa-tubulin in lung cancer cells
201328 citationsauthor #1
OS1. gastric cancer
20120 citationsauthor #3
Integrated analysis of whole genome exon array and array‐comparative genomic hybridization in gastric and colorectal cancer cells
201221 citationsauthor #6
Slug Increases Sensitivity To Tubulin Binding Agents Via The Downregulation Of Beta III And IVa-Tubulin In Lung Cancer Cells
201211 citationsauthor #1
SRPX2 Is a Novel Chondroitin Sulfate Proteoglycan That Is Overexpressed in Gastrointestinal Cancer
201240 citationsauthor #3
Aza-derivatives of resveratrol are potent macrophage migration inhibitory factor inhibitors
201223 citationsauthor #6
Abstract 3406: Impact of TJP-1 and TWIST expression on post-operative prognosis in hepatocellular carcinoma
20121 citationsauthor #7
Abstract 1095: Short Poly A sequence in HGF promoter region is involved in overexpression of HGF in cancer cells
20110 citationsauthor #7
TGF-β induces sustained upregulation of SNAI1 and SNAI2 through Smad and non-Smad pathways in a human corneal epithelial cell line.
201169 citationsauthor #5
Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer
201197 citationsauthor #5
Abstract 1099: Aza-derivatives of resveratrol are potent inhibitors of macrophage migration inhibitory factor (MIF)
20110 citationsauthor #9
Abstract 5207: FGFR inhibitor regulates CD133 expression in FGFR2-amplified gastric cancer cells
20110 citationsauthor #7
Acquired drug resistance to vascular endothelial growth factor receptor 2 tyrosine kinase inhibitor in human vascular endothelial cells.
201136 citationsauthor #9
Sorafenib Inhibits the Hepatocyte Growth Factor–Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma
2011122 citationsauthor #7
Abstract 370: Characterization of human umbilical vein endothelial cell clones resistant to VEGFR2 tyrosine kinase inhibitor
20100 citationsauthor #8
Abstract 2156: Integration of whole genome exon array and array CGH analysis in gastric and colorectal cancer cell lines
20100 citationsauthor #5
FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth.
2010187 citationsauthor #4
Antitumor Activity of BIBF 1120, a Triple Angiokinase Inhibitor, and Use of VEGFR2+pTyr+ Peripheral Blood Leukocytes as a Pharmacodynamic Biomarker In Vivo
201037 citationsauthor #9
Abstract 3893: Overexpression of FOXQ1 is important factor in tumorigenicity and tumor growth
20101 citationsauthor #4
Tgf-β Induces Epithelial Mesenchymal Transition With Snai1 and Snai2 Up-Regulation in Human Corneal Epithelial Cells
20100 citationsauthor #5
Abstract 3994: Expression levels of EGFR-ligands are up-regulated in EGFR tyrosine kinase inhibitor-resistant cell line
20100 citationsauthor #7
Abstract 2296: Sorafenib inhibits hepatocyte growth factor-induced epithelial mesenchymal transition in hepatocellular carcinoma
20100 citationsauthor #7
Bortezomib potentially inhibits cellular growth of vascular endothelial cells through suppression of G2/M transition
201058 citationsauthor #1
mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells.
2009156 citationsauthor #7
Abstract #2671: Antitumor activity and mode of action of pentacyclic oxindole alkaloids from Uncaria tomentosa
20091 citationsauthor #7
Tgf-β Regulates Proliferation and Emt-Related Gene Expression of Human Corneal Epithelial Cell
20090 citationsauthor #5
Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone.
200879 citationsauthor #1
Prognostic Relevance of Clinical Symptoms in Patients with Spinal Metastases
200576 citationsauthor #3
Zoledronic Acid Inhibits Visceral Metastases in the 4T1/luc Mouse Breast Cancer Model
2004249 citationsauthor #4
Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer
200370 citationsauthor #3
C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis.
2003182 citationsauthor #5

TIMELINE

2003 252 citations

2004 249 citations

2005 76 citations

2008 79 citations

2009 157 citations

2010 283 citations

2011 324 citations

2012 96 citations

2013 28 citations

2016 22 citations

D. Tamura

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT